<DOC>
	<DOCNO>NCT02644252</DOCNO>
	<brief_summary>There need improve effect first-line chemotherapy lung cancer patient , preferably use approach none side effect . In trial investigator incorporate δ-tocotrienol/placebo nutritional supplement top standard chemotherapy patient advance non-small cell lung cancer .</brief_summary>
	<brief_title>Tocotrienol Nutritional Supplement Patients With Advanced Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<criteria>Histologically confirm nonsmall cell lung cancer , include squamous cell carcinoma , adenocarcinomas nonneuroendocrine large cell carcinoma Patients advance stage NSCLC candidate firstline platinumbased doublet chemotherapy Measurable disease RECIST 1.1 Age ≥ 18 year . Performance status 02 . Adequate bone marrow function , liver function , renal function ( within 7 day prior inclusion ) : White blood cell ( WBC ) ≥ 3.0 * 10^9/l neutrophil ( ANC ) ≥ 1.5 * 10^9/l Platelet count ≥ 100 * 10^9/l Hemoglobin ≥ 6 mmol/l Serum bilirubin &lt; 2.0 * upper level normal ( ULN ) Serum transaminase ≤ 2.5 * ULN Serum creatinine ≤ 1.5 ULN Written orally inform consent . Other malignant disease within 5 year prior inclusion study , except curatively treat basal cell squamous cell carcinoma skin type cancer minimal risk recurrence . Other experimental therapy participation another clinical trial within 28 day prior treatment initiation . Patients receive prior chemotherapy NSCLC Patients NSCLC candidate neoadjuvant chemotherapy curative chemoradiotherapy Underlying disease adequately treat ( diabetes , cardiac disease ) Allergy active substance auxiliary agent Pregnant breastfeeding patient . For fertile woman negative pregnancy test screen mandatory . Fertile patient willing use effective method contraception treatment 6 month end treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>